It will indeed but I guess we will only see in time.
Cancer really has been the niche targeted by Phylogica over the longest period but these type of collaborations have been equally exciting each in their own time with world leading bodies - University of Cambridge's Molecular Therapeutics in conjunction with Hutchinson MRC &
Professor Ashock Venkitaraman in 2008 leading to the then supposed spin-off in 2011 which still hasn't occurred ? & even soon after listing in 2005 with Fox Chase Cancer Centre. Of course the technology is much more advanced today but at every point that these collaborations have been made it's also been at the front line.
It will indeed but I guess we will only see in time. Cancer...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |